Related Experiment Video
Updated: Mar 17, 2026

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
Published on: January 5, 2024
Cryptic prophages as targets for drug development
1Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301, PR China.
Bacteriophages integrate into bacterial DNA, influencing pathogen traits. Cryptic prophages act as permanent gene reservoirs, offering potential drug targets for combating bacterial infections and antibiotic resistance.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Bacterial chromosomes can incorporate significant amounts of phage DNA (up to 20%).
- This phage DNA contributes to bacterial metabolic capabilities, including virulence and antibiotic resistance.
- Active and cryptic prophages represent distinct categories with differing roles in bacterial pathogenesis.
Purpose of the Study:
- To investigate the role of proteins derived from active and cryptic prophages.
- To analyze their contribution to bacterial virulence, antibiotic resistance, and antibiotic tolerance.
- To identify cryptic prophages as potential targets for novel drug development.
Main Methods:
- Analysis of prophage DNA integrated into bacterial chromosomes.
- Examination of protein products encoded by prophage genes.
- Assessment of the impact of prophage-derived proteins on bacterial phenotypes.
Main Results:
- Active prophages can excise and spread, carrying virulence and resistance genes.
- Cryptic prophages serve as stable reservoirs of beneficial genes for pathogens.
- Cryptic prophages contribute to antibiotic tolerance via toxin/antitoxin loci.
Conclusions:
- Prophage-derived proteins significantly influence bacterial pathogenicity.
- Cryptic prophages are crucial for maintaining genetic traits in pathogens.
- Targeting cryptic prophages presents a promising strategy for developing new antimicrobial therapies.
More Related Videos
08:25Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
Published on: March 20, 2016
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Lysogenic Cycle of Bacteriophages